Major finding: The E3 ubiquitin ligase Mule specifically targets HDAC2 for degradation.

Mechanism: Accumulation of HDAC2 blocks p53 acetylation and p53-dependent apoptosis.

Impact: Deregulation of Mule expression in cancer cells may affect the response to HDAC inhibitors.

This content is only available via PDF.